Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Clinical Genetics

Decoding Your Genes: A Guide to Genetic Testing Results

At a Glance

Genetic testing for MC4R deficiency helps explain severe early-onset obesity and extreme hunger. A genetic report will show if you have a pathogenic gene variant causing the condition, which guides personalized treatment and helps identify other at-risk family members.

If you have reached the stage of genetic testing, you are moving from guessing to gathering hard biological evidence. Genetic testing is now recommended for children who experience severe obesity at a very young age (typically before age 5) and for those who have intense, constant hunger known as hyperphagia [1][2].

The Blueprint: How MC4R is Inherited

Humans carry two copies of the MC4R gene—one from each parent. How these copies are affected determines the severity of the condition:

  • Homozygous or Compound Heterozygous: Both copies of the gene have a “glitch.” This usually leads to severe, morbid obesity that begins very early in life, often in infancy [3][4].
  • Heterozygous: Only one copy of the gene has a “glitch.” This is much more common. While it can occasionally result in milder symptoms, it still frequently causes severe early-onset obesity and intense hyperphagia [3][5]. Because of variable penetrance—meaning two people with the exact same genetic glitch might have totally different levels of hunger—symptoms can vary significantly.

Testing Family Members

Because this is an inherited condition, a diagnosis often means other family members could be affected. If you or your child test positive, your clinical geneticist will likely recommend testing for close family members (like siblings or parents) to help them understand their own metabolic risks and options [6][7].

Decoding Your Genetic Report

A genetic test report can look like a different language. Here is a checklist of the most important terms you will see under “Variant Classification”:

  • Pathogenic: This is a confirmed “glitch” that is known to cause the condition [8].
  • Likely Pathogenic: Doctors are about 90% sure this variant causes the condition, based on current evidence [8].
  • Variant of Uncertain Significance (VUS): This is a “maybe.” There isn’t enough research yet to know if this specific change is harmful or just a normal variation. These often require re-evaluation over time as more data becomes available [9][8].

Which Test Is Right?

Your doctor may suggest one of two main types of tests:

  1. Targeted Multigene Panel: This test looks only at a specific group of genes known to cause obesity (like MC4R, POMC, and LEPR). It is often faster and more cost-effective [10][11].
  2. Whole Exome Sequencing (WES): This test looks at almost every gene in your body. It is often used if a targeted panel comes back negative but a genetic cause is still strongly suspected [12][13].

Nature vs. Nurture

It is important to remember that genetics are not “destiny”—they are a blueprint. While a mutation in the MC4R gene makes you much more susceptible to weight gain, your environment still plays a role.

For example, people with MC4R “glitches” often show a much stronger weight response to high-calorie food or fast-food environments than people without the mutation [14][15]. This means that while your genetics create the risk, specialized management of your environment and diet can still help mitigate that risk, though it may be much harder than it is for others [16][17]. Diagnosing the “glitch” is the first step in creating a plan that actually works for your specific biology [18][19].

Common questions in this guide

What does a Variant of Uncertain Significance (VUS) mean on my genetic report?
A VUS means there is a change in your MC4R gene, but there isn't enough research yet to know if it causes obesity. Your clinical geneticist may recommend re-evaluating this result over time or performing functional studies as more scientific data becomes available.
What is the difference between homozygous and heterozygous MC4R mutations?
Homozygous means both copies of the MC4R gene have a mutation, which usually causes severe obesity very early in life. Heterozygous means only one copy is affected, which is more common and can cause varying levels of intense hunger and weight gain.
Who should get genetic testing for MC4R deficiency?
Genetic testing is generally recommended for children who develop severe obesity before the age of 5. It is also recommended for individuals of any age who experience extreme, constant hunger known as hyperphagia.
Should my family members be tested if I have an MC4R mutation?
Because MC4R deficiency is an inherited condition, your clinical geneticist will likely recommend testing for close family members like parents or siblings. This helps them understand their own metabolic risks and healthcare options.
Does a positive MC4R test mean I can't manage my weight?
While an MC4R mutation makes you highly susceptible to weight gain and intense hunger, genetics are just a blueprint. Specialized management of your diet and environment, along with potential targeted therapies, can help mitigate these risks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My report says the variant is a 'VUS'—is there any way to perform a functional study to see if it's actually causing my/my child's hunger?
  2. 2.Is this mutation 'heterozygous' or 'homozygous,' and how does that change the way we should manage it?
  3. 3.Does this specific variant qualify me/my child for targeted therapies or active clinical trials?
  4. 4.Since I/my child have this genetic risk, what specific environmental or dietary changes will be most effective for us?
  5. 5.Should other family members be tested for this same MC4R variant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.

    Hinney A, Körner A, Fischer-Posovszky P

    Nature reviews. Endocrinology 2022; (18(10)):623-637 doi:10.1038/s41574-022-00716-0.

    PMID: 35902734
  2. 2

    A new homozygous pathogenic LEPR variant causing severe, early onset obesity in a Senegalese child.

    Deswarte V, Lebreton L, Barat P, et al.

    Obesity research & clinical practice 2025; (19(3)):279-282 doi:10.1016/j.orcp.2025.04.007.

    PMID: 40335422
  3. 3

    Heterozygous versus homozygous phenotype caused by the same MC4R mutation: novel mutation affecting a large consanguineous kindred.

    Drabkin M, Birk OS, Birk R

    BMC medical genetics 2018; (19(1)):135 doi:10.1186/s12881-018-0654-1.

    PMID: 30068297
  4. 4

    Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016.

    Huvenne H, Dubern B, Clément K, Poitou C

    Obesity facts 2016; (9(3)):158-73 doi:10.1159/000445061.

    PMID: 27241181
  5. 5

    Single nucleotide polymorphisms (SNPs) that are associated with obesity and type 2 diabetes among Asians: a systematic review and meta-analysis.

    Yanasegaran K, Ng JYE, Chua EW, et al.

    Scientific reports 2024; (14(1)):20062 doi:10.1038/s41598-024-70674-2.

    PMID: 39209904
  6. 6

    Clinical and molecular characterisation of children with monogenic obesity: a case series.

    George A, Navi S, Nanda P, et al.

    Pediatric endocrinology, diabetes, and metabolism 2024; (30(2)):104-109 doi:10.5114/pedm.2024.140934.

    PMID: 39026488
  7. 7

    Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study.

    Folon L, Baron M, Toussaint B, et al.

    The lancet. Diabetes & endocrinology 2023; (11(3)):182-190 doi:10.1016/S2213-8587(22)00392-8.

    PMID: 36822744
  8. 8

    Functional characterization of all missense variants in LEPR, PCSK1, and POMC genes arising from single-nucleotide variants.

    Shah BP, Sleiman PM, Mc Donald J, et al.

    Expert review of endocrinology & metabolism 2023; (18(2)):209-219 doi:10.1080/17446651.2023.2179985.

    PMID: 36864747
  9. 9

    Genetic Insights into Severe Obesity: A Case Study of MC4R Variant Identification and Clinical Implications.

    Imangaliyeva A, Sikhayeva N, Bolatov A, et al.

    Genes 2025; (16(5)) doi:10.3390/genes16050508.

    PMID: 40428329
  10. 10

    Targeted Next-Generation Sequencing of the Leptin-Melanocortin Pathway in Severe Obesity.

    Faccioli N, Poitou C, Georget M, et al.

    Obesity (Silver Spring, Md.) 2026; (34(2)):499-511 doi:10.1002/oby.70107.

    PMID: 41451896
  11. 11

    Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.

    Arunachalam AK, Maddali M, Aboobacker FN, et al.

    Journal of clinical immunology 2021; (41(2)):393-413 doi:10.1007/s10875-020-00923-2.

    PMID: 33225392
  12. 12

    Comparative genetic diagnostic evaluation of pediatric neuromuscular diseases in a consanguineous population.

    Al-Hedaithy A, Alghamdi F, Almomen M, et al.

    Scientific reports 2025; (15(1)):231 doi:10.1038/s41598-024-81744-w.

    PMID: 39747233
  13. 13

    Male pseudohermaphroditism: A case study of 46,XY disorder of sexual development using whole-exome sequencing.

    Naumova OY, Rychkov SY, Burenkova OV, et al.

    Clinical case reports 2020; (8(12)):2889-2894 doi:10.1002/ccr3.3286.

    PMID: 33363845
  14. 14

    Exploring the interplay of genetic variants and environmental factors in childhood obesity: A systematic review and meta-analysis.

    Zhu H, Yi X, He M, et al.

    Metabolism: clinical and experimental 2025; (170()):156303 doi:10.1016/j.metabol.2025.156303.

    PMID: 40412510
  15. 15

    Genetic risk of obesity as a modifier of associations between neighbourhood environment and body mass index: an observational study of 335 046 UK Biobank participants.

    Mason KE, Palla L, Pearce N, et al.

    BMJ nutrition, prevention & health 2020; (3(2)):247-255 doi:10.1136/bmjnph-2020-000107.

    PMID: 33521535
  16. 16

    Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications.

    Goodarzi MO

    The lancet. Diabetes & endocrinology 2018; (6(3)):223-236 doi:10.1016/S2213-8587(17)30200-0.

    PMID: 28919064
  17. 17

    Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study.

    Celis-Morales CA, Lyall DM, Petermann F, et al.

    International journal of obesity (2005) 2019; (43(8)):1526-1538 doi:10.1038/s41366-019-0381-5.

    PMID: 31168053
  18. 18

    Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations.

    Trier C, Hollensted M, Schnurr TM, et al.

    International journal of obesity (2005) 2021; (45(1)):66-76 doi:10.1038/s41366-020-00673-6.

    PMID: 32921795
  19. 19

    Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity.

    Pressley H, Cornelio CK, Adams EN

    The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2022; (38(6)):368-373 doi:10.1177/87551225221116010.

    PMID: 36311304

This page explains MC4R genetic testing terminology for educational purposes only. Always consult your clinical geneticist or endocrinologist to interpret your specific genetic report and medical options.

Get notified when new evidence is published on Obesity due to melanocortin 4 receptor deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.